Skip to content

Can virtual reality-based meditation help reduce anxiety and depression in patients newly diagnosed with acute leukemia?

Effect of virtual reality combined with meditation on alleviating anxiety and depression among acute leukemia patients during induction chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN84842464
Enrollment
70
Registered
2022-06-06
Start date
2021-01-13
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of anxiety and depression during induction chemotherapy in previously untreated patients newly diagnosed with acute leukemia Mental and Behavioural Disorders

Interventions

Randomization: Random assignment to the intervention group and control group will be performed by SPSS 24.0 at a proportion of 1:1. The 70 generated codes will be written on the same s

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed with acute leukemia, including acute myeloid leukemia and acute lymphocytic leukemia 2. No relevant previous treatment 3. Aged 18 years and over 4. Normal cognition and comprehension 5. Karnofsky Performance Status >60

Exclusion criteria

Exclusion criteria: 1. Aggravation in related symptoms, such as severe infection, bleeding, or anemia 2. Complicated with other neoplastic diagnoses 3. In a critical condition 4. Accompanied eye-related diseases 5. Refused participation or participating in other studies

Design outcomes

Primary

MeasureTime frame
1. Anxiety is measured using State Anxiety Inventory at baseline and post-intervention (2 weeks) 2. Depression is measured using the Center for Epidemiological Studies Depression Scale at baseline and post-intervention (2 weeks)

Secondary

MeasureTime frame
Quality of life is measured using The Functional Assessment of Cancer Therapy-Leukemia Questionnaire at baseline and post-intervention (2 weeks).

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026